Palisade Bio earnings were -$13.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest PALI earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$2.2M, down 33.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PALI reported annual earnings of -$14.4M, with 17.2% growth.
On PALI's earnings call on Invalid Date, Palisade Bio (NASDAQ: PALI) reported Q1 2025 earnings per share (EPS) of -$0.47, up 89.76% year over year. Total PALI earnings for the quarter were -$2.23 million. In the same quarter last year, Palisade Bio's earnings per share (EPS) was -$4.59.
As of the last Palisade Bio earnings report, Palisade Bio is currently losing money. Palisade Bio's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$13.14 million, a 2.68% decrease year over year.
What was PALI's earnings growth in the past year?
As of Palisade Bio's earnings date in Invalid Date, Palisade Bio's earnings has grown year over year. PALI earnings in the past year totalled -$13.14 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.